IQVIA™ Real-World Insights Bibliography

Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany
Author(s): Rui Cai 1, Laetitia Gerlier 2, Martin Eichner 3 4, Markus Schwehm 5, Sankarasubramanian Rajaram 6, Joaquin Mould-Quevedo 7, Mark Lamotte 2
Affiliations(s): 1IQVIA Real World Solutions, Amsterdam, The Netherlands. 2IQVIA (Global HEOR), Zaventem, Belgium. 3Epimos GmbH, Dusslingen, Germany. 4Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. 5ExploSYS GmbH, Leinfelden-Echterdingen, Germany. 6Seqirus Vaccines Ltd, Maidenhead, UK. 7Seqirus Vaccines, Summit, NJ, USA
Publication(s):  Journal of Medical Economics 2021. https://doi.org/10.1080/13696998.2021.1908000
Document Type(s): Article,
Countries: Germany,
Click here for the abstract
C:
Y:
Immunology and Vaccination,
2021
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults ? A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study)
Author(s): Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas
Affiliations(s): University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States
Publication(s): 
Document Type(s): Article,
Countries: Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA,
Click here for the abstract
C:
Y:
Infectious disease,
2021
  L:
A:
English
Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study,
  Add to report
 
 
Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany
Author(s): Kasper S, Bonelli A, Cattaneo A, Comandini A, Di Dato G, Heiman F, Pegoraro V, Palao D, Roca M, Volz HP
Affiliations(s): Kasper S: Center for Brain Research, Medical University of Vienna, Austria; Pegoraro V, Heiman F: IQVIA Solutions Italy S.r.l., RWS
Publication(s):  Int J Psychiatry Clin Pract. 2021 Sep 20:1-10. doi: 10.1080/13651501.2021.1972120. Epub ahead of print. PMID: 34543170.
Document Type(s): Article,
Countries: Germany,
Click here for the abstract
C:
Y:
Mental health,
2021
  L:
A:
English
Clinical setting: Primary care, Epidemiological study, Retrospective database analysis,
  Add to report
 
 
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study
Author(s): Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain
Publication(s):  IPVC, Barcelona, Spain, 23-27 March 2020
Document Type(s): Oral presentation,
Countries: China, France, Germany, Italy, Japan, Portugal, Spain,
C:
Y:
Infectious disease, Oncology,
2020
  L:
A:
English
Burden of illness, Observational study, Retrospective Field Study,
  Add to report
 
 
The prevalence of polypharmacy and the use of potentially inappropriate medications (PIMs): a cross-national study in five European countries - Preliminary Results
Author(s): Bennie M1, Elseviers M2, Schubert I3, Poluzzi E4, MacBride S5, Sermet C6, Jouaville Abrouk LS7, Menon S7, Trehony J7, Nasuti P7, Taxis K8
Affiliations(s): 1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde / Information Services Division, NHS National Services Scotland, UK 2 Clinical Pharmacology, Ghent University, Belgium Centre for Innovation and Care, University of Antwerp, Belgium 3 PMV Research Group, Faculty of Medicine and University Hospital of Cologne, University for Cologne, Germany 4 University of Bologna, Italy 5 NHS Greater Glasgow and Clyde, Scotland 6 IRDES, Institut de Recherche en Economie de la Santé, France 7 IQVIA Real World Solutions, London, UK / France 8 University of Groningen, PharmacoTherapy, Epidemiology and Economics, Groningen, The Netherlands
Publication(s):  European Drug Utilisation Resarch Group (EuroDURG) Conference 2020, Szeged, Hungary, 4-7 March 2020
Document Type(s): Poster,
Countries: Belgium, France, Germany, Italy, UK,
C:
Y:
Clinical practice, Public Health,
2020
  L:
A:
English
Population Based Study, Public Health, Retrospective database analysis,
  Add to report
 
 
Predictors of iron?deficiency anemia in primary care older adults: a real?world European multi?country longitudinal study
Author(s): Vetrano DL, Zucchelli A, Marconi E, Levi M, Pegoraro V, Cataldo N, Heiman F, Cricelli C, Lapi F
Affiliations(s): Vetrano DL: Department of Geriatrics, Catholic University of Rome and IRCCS Fondazione Policlinico ?A. Gemelli?, Rome, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy
Publication(s):  Aging Clin Exp Res (2020). https://doi.org/10.1007/s40520-019-01454-6
Document Type(s): Article,
Countries: Belgium, Germany, Italy, Spain,
Click here for the abstract
C:
Y:
Hematology,
2020
  L:
A:
English
Epidemiological study, Retrospective database analysis,
  Add to report
 
 
An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in Germany
Author(s): Jieling Chen1, Magaly Perez-Nieves1, Carolina Piras De Oliveira1, Erik Spaepen2, Beatrice Osumili3, Jiat Ling Poon1, Nanette Schloot2, Nuria Lara4, Laura Garcia Alvarez4, Montserrat Roset4
Affiliations(s): 1 Eli Lilly and Company, Indianapolis, US 2 Eli Lilly and Company, HaaPACS GmbH, Schriesheim, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Real World Solutions, Barcelona, Spain
Publication(s):  Postgraduate Medicine
Document Type(s): Article,
Countries: Germany,
Click here for the abstract
C:
Y:
Diabetes,
2020
  L:
A:
English
Compliance,
  Add to report
 
 
An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in Germany
Author(s): Jieling Chen1, Magaly Perez-Nieves1, Carolina Piras De Oliveira1, Erik Spaepen2, Beatrice Osumili3, Jiat Ling Poon1, Nanette Schloot2, Nuria Lara4, Laura Garcia Alvarez4, Montserrat Roset4
Affiliations(s): 1 Eli Lilly and Company, Indianapolis, US 2 Eli Lilly and Company, HaaPACS GmbH, Schriesheim, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Real World Solutions, Barcelona, Spain
Publication(s):  Postgraduate Medicine
Document Type(s): Article,
Countries: Germany,
Click here for the abstract
C:
Y:
Diabetes,
2020
  L:
A:
English
Compliance,
  Add to report
 
 
Cost-Effectiveness of the CELL-Based Quadrivalent Versus the Standard Egg-Based Quadrivalent Influenza Vaccine in Germany. Results of a Dynamic Transmission Modelling Approach
Author(s): Cai R, Gerlier L, Eichner M, Schwehm M, Majaram S, Mould-Quevedo J, Lamotte M.
Affiliations(s): IQVIA HEOR Zaventem
Publication(s):  ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 105463
Document Type(s): Poster,
Countries: Germany,
C:
Y:
Immunology and Vaccination,
2020
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
Investigation of factors considered in the health technology assessment conducted by regulatory authority in eight countries
Author(s): Akira Yuasa 1, Naohiro Yonemoto 1, Sven Demiya 2, Chihiro Foellscher 2, Shunya Ikeda 3 (rwesheorj 2)
Affiliations(s): 1) Pfizer Japan Inc., Tokyo, Japan 2) IQVIA Solutions Japan, Tokyo, Japan 3) Graduate School of Medicine, International University of Health and Welfare, Tokyo, Japan
Publication(s):  ISPOR 2020 Conference
Document Type(s): Abstract,
Countries: Australia, Canada, France, Germany, Italy, Japan, Spain, UK,
Click here for the abstract
C:
Y:

2020
  L:
A:
English
  Add to report
 
 
 1 of 49 Next Page Last Page